Search for: "Endo Pharmaceuticals Inc. v. Sandoz Inc."
Results 1 - 20
of 31
Sorted by Relevance
|
Sort by Date
4 Apr 2010, 9:55 pm
Endo Pharmaceuticals Inc. 1:10-cv-00261; filed March 31, 2010 in the District Court of Delaware Infringement of U.S. [read post]
28 Aug 2009, 8:11 am
(patent infringement) 8/6: Ethicon Endo-Surgery Inc. v. [read post]
1 Dec 2009, 9:45 am
(patent infringement) 11/19: Allergan Inc., Allergan USA Inc., Allergan Sales, LLC, Endo Pharmaceuticals Solutions Inc., Supernus Pharmaceuticals Inc. v. [read post]
10 Feb 2010, 4:47 pm
Sandoz Inc. [read post]
10 Jun 2010, 3:58 am
Par Pharmaceutical, Inc. [read post]
23 Dec 2013, 5:16 am
Sandoz Inc., 921 F. [read post]
28 Sep 2016, 8:39 am
Momenta Pharmaceuticals, Inc., et al., No. 15-1402 (scope of 271(e) safe harbor) Post Grant Admin: Ethicon Endo-Surgery, Inc. v. [read post]
4 Mar 2016, 12:25 pm
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
13 Oct 2016, 6:50 am
Fossil, Inc., et al, No. 16-202 (SCA Redux plus TM issue) Post Grant Admin: Ethicon Endo-Surgery, Inc. v. [read post]
16 Jun 2010, 3:02 pm
Sandoz, Inc. [read post]
14 Nov 2016, 9:16 am
Fossil, Inc., et al, No. 16-202 (SCA Redux plus TM issue) Post Grant Admin: Ethicon Endo-Surgery, Inc. v. [read post]
16 Jan 2017, 5:44 pm
Post Grant Admin: Ethicon Endo-Surgery, Inc. v. [read post]
18 Apr 2016, 9:58 am
Sandoz, Inc., 135 S. [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation (IP Law Observer) Lescol (Fluvastatin) - US: Mylan confirms first-to-file patent challenge to Lescol by Novartis (SmartBrief) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd… [read post]
3 Jun 2016, 6:40 am
Seagate, No. 15-1285 (pre-invention assignment of future patent rights) Biologics Notice of Commercial Marketing: Sandoz Inc. v. [read post]
8 Feb 2017, 3:09 am
Briefing: Sandoz Inc. v. [read post]
1 Apr 2016, 8:22 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
5 Jul 2007, 10:37 am
App. 1974).Texas: Ethicon Endo-Surgery, Inc. v. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
28 Jun 2016, 6:41 am
(post-sale restrictions); and Sandoz v. [read post]
